Related Experiment Video
Updated: May 15, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
Fish oil supplementation for two generations increases insulin sensitivity in rats
Sandro M Hirabara1, Alessandra Folador, Jarlei Fiamoncini
1Institute of Physical Activity Sciences and Sport, Cruzeiro do Sul University, São Paulo, Brazil. sandromh@yahoo.com.br
The Journal of Nutritional Biochemistry
|December 19, 2012
Summary
Long-term fish oil supplementation across two generations improved insulin sensitivity in male rats. This enhancement in insulin sensitivity was linked to molecular changes in skeletal muscle and liver.
Area of Science:
- Nutritional Science
- Metabolic Health
- Molecular Biology
Background:
- Insulin resistance is a growing metabolic concern.
- Dietary interventions, like fish oil, are explored for metabolic benefits.
- Transgenerational effects of nutritional supplementation are not fully understood.
Purpose of the Study:
- To investigate the impact of two-generation fish oil supplementation on insulin sensitivity.
- To explore the molecular mechanisms underlying observed metabolic changes.
- To assess effects on glycemia, lipidemia, and insulin signaling pathways.
Main Methods:
- Female rats received fish oil or control diet for 3 months, then through gestation and lactation.
- Supplementation was continued for two subsequent generations (G1 and G2).
- Insulin sensitivity was assessed in male offspring (G1 and G2) using in vivo and in vitro methods; molecular analyses included kinase phosphorylation and DNA methylation.
Main Results:
- First-generation (G1) offspring showed no significant changes compared to controls.
- Second-generation (G2) offspring exhibited reduced blood glucose and lipids, with improved insulin sensitivity.
- Improvements in G2 were associated with increased p38 MAP kinase phosphorylation, a lower n-6/n-3 fatty acid ratio in skeletal muscle, and decreased global DNA methylation in the liver.
Conclusions:
- Two-generation fish oil supplementation can improve insulin sensitivity in offspring.
- The benefits appear in the second generation and are linked to specific molecular adaptations.
- Findings suggest potential for dietary strategies to influence metabolic health across generations.
Related Concept Videos
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...

